REMLIFETrading & Distributors
Remedium Lifecare Ltd — PE Ratio & Valuation Analysis
₹0.36
+0.00%
Current P/E44.72xPrice to earnings
Industry P/E35.45xSector average
4Y Avg P/E26.9x66.6% above avg
⚠️
26.1% Premium to Industry
REMLIFE P/E 44.72x vs sector avg 35.45x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹0.03 | ₹1 | 21.5x |
| 2024 | ₹0.57 | ₹5 | 9x |
| 2023 | ₹2.63 | ₹25 | 9.5x |
| 2022 | ₹0.02 | ₹1 | 67.4x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Remedium Lifecare Ltd Valuation
Remedium Lifecare Ltd (REMLIFE) currently trades at 44.72x earnings. The Trading & Distributors sector average PE is 35.45x. REMLIFE commands a premium, reflecting high growth expectations. Historically, REMLIFE has traded at an average PE of 26.9x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
N/A
Dividend Yield
0.00%
More on Remedium Lifecare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.